Isoborneol Attenuates Low-Density Lipoprotein Accumulation and Foam Cell Formation in Macrophages

PURPOSE: Isoborneol has been used in the treatment of cardiovascular disease for several years in China. However, the mechanism is still unclear. The aim of this study was to identify the novel mechanism of isoborneol for its application in atherosclerotic disease. MATERIALS AND METHODS: The whole-g...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yunfei, Li, Zhengrong, Liu, Boxue, Wu, Rumeng, Gong, Haifeng, Su, Zhanhai, Zhang, Shoude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970257/
https://www.ncbi.nlm.nih.gov/pubmed/32021101
http://dx.doi.org/10.2147/DDDT.S233013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970257/
https://www.ncbi.nlm.nih.gov/pubmed/32021101
http://dx.doi.org/10.2147/DDDT.S233013

Ejemplares similares